QualTek Molecular Laboratories

QualTek Molecular Laboratories is a renowned provider of immunohistochemistry (IHC) services with CAP/CLIA-accredited and Good Laboratory Practice-(GLP) capable laboratories. Established in 1997, the company has positioned itself as a leading entity in the Biopharma industry.

With a strong emphasis on quality and compliance, QualTek has garnered significant attention within the sector. The company's dedication to maintaining both CAP and CLIA accreditations underscores its commitment to adhering to the highest standards in laboratory testing and analysis.

While details regarding headquarters, last investment, and investors are not currently available, QualTek Molecular Laboratories' track record and specialized focus make it an intriguing potential investment opportunity. As the biopharmaceutical industry continues to evolve, the expertise and capabilities offered by QualTek hold substantial promise for both growth and impact within the sector.